Addex Pharma S.A.
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy (NCT05116813) | Addex Pharma S.A. | 2021-10-25 |
| Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm (NCT05027997) | Addex Pharma S.A. | 2021-10-06 |
| Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy (NCT04857359) | Addex Pharma S.A. | 2021-08-06 |
Track Addex Pharma S.A. automatically
Every clearance here is in the API, with alerts when new ones post.